ELIZA RIVERA-MITU: Open Payments
NPI 1104167758 · FOUNTAIN VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 11 payments from 6 companies in 2025. Trend: 2023 $371 · 2024 $218 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $258 |
| Alkermes, Inc. | 2 | $247 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
Products named: INVEGA SUSTENNA, Kerendia, ARISTADA, LYBALVI, COBENFY, CAPLYTA, UZEDY, AUSTEDO XR.
Industry payments across CA — which companies pay providers there.
